Placenta
Volume 29, Issue 2 , Pages 135-143 , February 2008

Proteomics of the Human Placenta: Promises and Realities

  • J.M. Robinson

      Affiliations

    • Department of Physiology and Cell Biology, Ohio State University, 304 Hamilton Hall, 1645 Neil Avenue, Columbus, OH 43210, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 614 292 9663; fax: +1 614 292 4888.
    • ,
  • W.E. Ackerman IV

      Affiliations

    • Department of Obstetrics and Gynecology (Laboratory of Perinatal Research and Division of Maternal-Fetal Medicine), Ohio State University, Columbus, OH 43210, USA
    • ,
  • D.A. Kniss

      Affiliations

    • Department of Obstetrics and Gynecology (Laboratory of Perinatal Research and Division of Maternal-Fetal Medicine), Ohio State University, Columbus, OH 43210, USA
    • Department of Biomedical Engineering, Ohio State University, Columbus, OH 43210, USA
    • ,
  • T. Takizawa

      Affiliations

    • Department of Molecular Anatomy, Nippon Medical School, Tokyo, Japan
    • ,
  • D.D. Vandré

      Affiliations

    • Department of Physiology and Cell Biology, Ohio State University, 304 Hamilton Hall, 1645 Neil Avenue, Columbus, OH 43210, USA

,Accepted 11 December 2007.

References 

  1. Godovac-Zimmermann J, Kleiner O, Brown LR, Drukier AK. Perspectives in spicing up proteomics with splicing. Proteomics. 2005;5:699–709
  2. Romero R, Espinoza J, Gotsch F, Kusanovic JP, Friel LA, Erez O, et al. The use of high-dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome. BJOG. 2006;113:118–135
  3. Archakov AI, Ivanov YD. Analytical nanobiology for medicine diagnostics. Mol Biosyst. 2007;3:336–342
  4. Moseley FL, Bicknell KA, Marber MS, Brooks G. The use of proteomics to identify novel therapeutic targets for treatment of disease. J Pharm Pharmacol. 2007;59:609–628
  5. Morón JA, Devi LA. Use of proteomics for the identification of novel targets in brain disease. J Neurochem. 2007;102:306–315
  6. Marko-Varga G, Ogiwara A, Nishimura T, Kawamaura T, Fujii K, Kawakami Y, et al. Personalized medicine and proteomics: lessons from non-small cell lung cancer. J Proteome Res. 2007;6:2925–2935
  7. Huber LA. Is proteomics heading in the wrong direction?. Nature Rev Mol Cell Biol. 2003;4:74–80
  8. Anderson NL, Anderson NG. Proteome and proteomics: new technologies, new concepts, and new ideas. Electrophoresis. 1998;19:1853–1861
  9. Corthals GL, Wasinger VC, Hochstrasser DF, Sanchez J-C. The dynamic range of protein expression: a challenge for proteomics research. Electrophoresis. 2000;21:1104–1115
  10. Gygi SP, Corthals GL, Zhang Y, Rochon Y, Aebersold R. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc Natl Acad Sci USA. 2000;97:9390–9395
  11. Righetti PG, Castagna A, Herbert B, Candiano G. How to bring the ‘unseen’ proteome to the limelight via electrophoretic pre-fractionation techniques. Biosci Rep. 2005;25:3–17
  12. Grabis S, Lubec G, Fountoulakis M. Limitations of current proteomics technologies. J Chromatogr A. 2005;1077:1–18
  13. Luche S, Santoni V, Rabilloud T. Evaluation of nonionic and zwitterionic detergents as membrane protein solubilizers in two-dimensional electrophoresis. Proteomics. 2003;3:249–253
  14. Hu Y, Huang X, Chen GYJ, Yao SQ. Recent advances in gel-based proteome profiling techniques. Mol Biotechnol. 2004;28:63–76
  15. Ahmed N, Rice GE. Strategies for revealing lower abundance proteins in two-dimensional protein maps. J Chromatogr B. 2005;815:39–50
  16. Zahedi R-P, Meisinger C, Sickmann A. Two-dimensional benzyldimethyl-n-hexadecylammonium chloride/DSD-PAGE for membrane proteomics. Proteomics. 2005;5:3581–3588
  17. Schindler J, Nothwag HG. Aqueous polymer two-phase systems: effective tools for plasma membrane proteomics. Proteomics. 2006;6:5409–5417
  18. Slomianny MC, Dupont A, Bouanou F, Beseme O, Guihot AL, Amouyel P, et al. Profiling of membrane proteins from human macrophages: comparison of two approaches. Proteomics. 2006;6:2365–2375
  19. Bodzon-Kulakowska A, Bierczynska-Krzysik A, Dylag T, Drabik A, Suder P, Noga M, et al. Methods for sample preparation in proteomics research. J Chromatogr B. 2007;849:1–31
  20. Lopez JL. Two-dimensional electrophoresis in proteome expression analysis. J Chromatogr B. 2007;849:190–202
  21. Canas B, Pineiro C, Calvo E, Lopez-Ferrer D, Gallardo JM. Trends in sample preparation for classical and second generation proteomics. J Chromatogr A. 2007;1153:235–258
  22. Rabilloud T, Luche S, Santoni V, Chevallet M. Detergents and chaotropes for protein solubilization before two-dimensional electrophoresis. Methods Mol Biol. 2007;355:111–119
  23. Rice GE, Georgiou HM, Ahmed N, Shi G, Kruppa G. Translational proteomics: Developing a predictive capacity—a review. Placenta. 2006;27(Suppl. A):S76–S86
  24. Stasyk LF, Huber LA. Zooming in: fractionation strategies in proteomics. Proteomics. 2004;4:3704–3716
  25. Dreger M. Subcellular proteomics. Mass Spectrometry Rev. 2003;22:27–56
  26. Righetti PG, Castagna A, Herbert B, Reymond F, Rossier JS. Prefractionation techniques in proteome analysis. Proteomics. 2003;3:1397–1407
  27. Au CE, Bell AW, Gilchrist A, Hiding J, Nilsson T, Bergeron JJM. Cellular proteomics to create the cell map. Curr Opin Cell Biol. 2007;19:376–385
  28. MacLellan DL, Steen H, Adam RM, Garlick M, Zurakowski D, Gygi SP, et al. A quantitative proteomic analysis of growth factor-induced compositional changes in lipid rafts of human smooth muscle cells. Proteomics. 2005;5:4733–4742
  29. Gupta N, Wollscheid B, Watts JD, Scheer B, Aebersold R, DeFranco AL. Quantitative proteomic analysis of B cell lipid rafts reveals that ezrin regulates antigen receptor-mediated lipid raft dynamics. Nat Immunol. 2006;7:625–633
  30. Dasari S, Pereira L, Reddy AP, Michaels J-E, Lu X, Jacob T, et al. Comprehensive proteomics analysis of human cervical-vaginal fluid. J Proteome Res. 2007;6:1258–1268
  31. Pereira L, Reddy AP, Jacob T, Thomas A, Schneider KA, Dasari S, et al. Identification of novel biomarkers of preterm birth in human cervical–vaginal fluid. J Proteome Res. 2007;6:1269–1276
  32. Buhimschi I, Christner R, Buhimschi CS. Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation. BJOG. 2005;112:173–181
  33. Michel PE, Crettaz D, Morier P, Heller M, Gallot D, Tissot J-D, et al. Proteome analysis of human plasma and amniotic fluid by Off-Gel™ isoelectric focusing followed by nano-LC-MS/MS. Electrophoresis. 2006;27:1169–1181
  34. Tsangaris GT, Karamessinis P, Kolialexi A, Garbis SD, Antsaklis A, Mavrou A, et al. Proteomics analysis of amniotic fluid in pregnancies with Down syndrome. Proteomics. 2006;6:4410–4419
  35. Shankar R, Gude N, Cullinane F, Brennecke S, Purcell AW, Moses EK. An emerging role for comprehensive proteome analysis in human pregnancy research. Reproduction. 2005;129:685–696
  36. Webster RP, Myatt L. Elucidation of the molecular mechanisms of pre-eclampsia using proteomics technologies. Proteomics-Clin Appl. 2007;1:1147–1157
  37. Hoang VM, Foulk R, Clauser K, Burlinggame A, Gibson BW, Fisher SJ. Functional proteomics: examining the effects of hypoxia on the cytotrophoblast protein repertoire. Biochemistry. 2001;40:4077–4086
  38. Anderson JS, Lam YW, Leung AK, Ong SE, Lyon CE, et al. Nucleolar proteome dynamics. Nature. 2005;433:77–83
  39. Wittmann-Liebold B, Graack H-R, Pohl T. Two-dimensional gel electrophoresis as tool for proteomics studies in combination with protein identification by mass spectrometry. Proteomics. 2006;6:4688–4703
  40. Santoni V, Molloy M, Rabilloud T. Membrane proteins and proteomics: Un amour impossible?. Electrophoresis. 2000;21:1054–1070
  41. Sawicki G, Dakour J, Morrish DW. Functional proteomics of neurokinin B in the placenta indicated a novel role in regulating cytotrophoblast antioxidant defenses. Proteomics. 2003;3:2044–2051
  42. Page NM, Woods RJ, Gardiner SM, Lomthaisong K, Gladwell RT, Butlin DJ, et al. Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia. Nature. 2000;405:797–800
  43. Sun LZ, Yang NN, De W, Xiao YS. Proteomics analysis of proteins differentially expressed in pre-eclamptic trophoblasts. Gynecol Obstet Invest. 2007;64:17–23
  44. Mine K, Katayama A, Matsumura T, Nishino T, Kuwabara Y, Ishikawa G, et al. Proteome analysis of human placentae: pre-eclampsia versus normal pregnancy. Placenta. 2007;28:676–687
  45. Webster RP, Brockman D, Myatt L. Nitration of p38 MAPK in the placenta: association of nitration with reduced catalytic activity of p38 MAPK in pre-eclampsia. Mol Human Reprod. 2006;12:677–685
  46. Liu A-X, Zhang W-W, Zhou T-H, Zhou C-Y, Yao W-M, Qian Y-L, et al. Proteomics analysis on the alteration of protein expression in the placental villous tissue of early pregnancy loss. Biol Reprod. 2006;75:414–420
  47. Butt RH, Lee MWY, Pirshahid SA, Backlund PS, Wood S, Coorssen JR. An initial proteomics analysis of human preterm labor: placental membranes. J Proteome Res. 2006;5:3161–3172
  48. Vorum H, Østergaard M, Hensechke P, Enghild JJ, Riazati M, Rice GE. Proteomic analysis of hyperoxia-induced responses in the human choriocarcinoma cell line JEG-3. Proteomics. 2004;4:861–867
  49. Hu R, Jin H, Zhou S, Yang P, Li X. Proteomics analysis of hypoxia-induced responses in the syncytialization of human placental cell line BeWo. Placenta. 2007;28:399–407
  50. Nampoothiri LP, Neelima PS, Rao AJ. Proteomic profiling of forskolin-induced differentiated BeWo cells: an in-vitro model of cytotrophoblast differentiation. Reprod BioMed Online. 2007;14:477–487
  51. Ishioka S-I, Ezaka Y, Umemura K, Hayashi T, Endo T, Saito T. Proteomic analysis of mechanisms of hypoxia-induced apotosis in trophoblastic cells. Int J Med Sci. 2007;4:36–44
  52. Paradela A, Bravo SB, Henriquez M, Riquelme G, Gavilanes F, Gonzalez-Ros JM, et al. Proteomic analysis of apical microvillous membranes of syncytiotrophoblast cells reveals a high degree of similarity with lipid rafts. J Proteome Res. 2005;4:2435–2441
  53. Carr S, Abersold R, Baldwin M, Burlinggame A, Clauser K, Nesvizskii A. The need for guidelines in publication of peptide and protein identification data. Working group on publication for peptide and protein identification data. Mol Cell Proteomics. 2004;3:531–533
  54. Wilkins MR, Appel RD, Van Eyk JE, Chung MCM, Görg A, Hecker M, et al. Guidelines for the next 10 years of proteomics. Proteomics. 2006;6:4–8
  55. Rabilloud T, Kieffer S, Procaccio V, Louwagie M, Courchesne PL, Patterson SD, et al. Two-dimensional electrophoresis of human placental mitochondria and protein identification by mass spectrometry: toward a human mitochondrial proteome. Electrophoresis. 1998;19:1006–1014
  56. Lescuyer P, Strub J-M, Luche S, Diemer H, Martinez P, Van Dorsselaer A, et al. Progress in the definition of a reference human mitochondrial proteome. Proteomics. 2003;3:157–167
  57. Kell DB, Oliver SG. Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis-driven science in the post-genomic era. BioEssay. 2004;26:99–105
  58. Jimenez V, Henriquez M, Llanos P, Riquelme G. Isolation and purification of human plasma membrane from normal and pre-eclamptic pregnancies. Placenta. 2004;25:422–437
  59. Jacobson BS, Stolz DE, Schnitzer JE. Plasma membrane isolation using the cationic colloidal silica isolation technique. In: Cells. A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1998;p. 35.1–35.14
  60. Durr E, Yu J, Krasinska KM, Carver LA, Yates JR, Testa JE, et al. Direct proteome mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nature Biotech. 2004;22:985–992
  61. Bretscher A. Microfilament structure and function in the cortical cytoskeleton. Annu Rev Cell Biol. 1991;7:337–374
  62. Fath KR, Burgess DR. Not actin alone. Curr Biol. 1995;5:591–593
  63. Vandré DD, Ackerman WE, Kniss DA, Tewari AK, Mori M, Takizawa T, et al. Dysferlin is expressed in human placenta but does not associate with caveolin. Biol Reprod. 2007;77:533–542
  64. Anderson LVB, Davison K, Moss JA, Young C, Cullen MJ, Walsh J, et al. Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet. 1999;8:855–861
  65. Bashir R, Britton S, Strachan T, Keers S, Vafiadaki E, Lako M, et al. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nature Genet. 1998;20:37–42
  66. Liu J, Aoki M, Illa I, Chenyan W, Fardeau M, Angelini C, et al. Dysferlin a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nature Genet. 1998;20:31–36
  67. Bansal Dm Miyake K, Vogel SS, Groh S, Chen CC, Williamson R, et al. Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature. 2003;423:168–172
  68. Lennon NJ, Kho A, Backai BJ, Perlmutter SL, Hyman BT, Brown RH. Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing. J Biol Chem. 2003;278:50466–50473
  69. Han R, Bansal D, Miyake K, Muniz VP, Weiss RM, McNeil PL, et al. Dysferlin-mediated membrane repair protects the heart from stress-induced left ventricular injury. J Clin Invest. 2007;117:1805–1818
  70. Huppertz V, Tews DS, Kaufmann P. Apotosis and syncytial fusion in human placental trophoblast and skeletal muscle. Int Rev Cytol. 2001;205:215–253
  71. Abumaree MH, Stone PR, Chamley LW. An in vitro model of human placental trophoblast deportation/shedding. Mol Hum Reprod. 2006;12:687–694

PII: S0143-4004(07)00306-2

doi: 10.1016/j.placenta.2007.12.005

Placenta
Volume 29, Issue 2 , Pages 135-143 , February 2008

Article Tools

* Image Usage & Resolution